GCC 0703 - A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma (ECOG2805)
GCC 0752 - A Randomized Trial of Temsirolimus and Sorafenib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma Who Have Failed First-Line Sunitinib Therapy
GCC 0785 - A Randomized Phase II Study of Docetaxel +/- ZD6474 (Zactima) in Metastatic Transitional Cell Carcinoma
GCC 0915 - RANDOMIZED, DOUBLE-BLIND PHASE 2 STUDY OF AXITINIB (AG-013736)
GCC 0917 - 0917 GCC: A Phase 1, Multicenter, Open-label, Dose-escalation, Multidose Study of MDX 1203 in Subjects with Advanced/Recurrent Clear Cell Renal Cell Carcinoma
Email this Page
Print this Page
